öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºËÕËØÎÄ
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º69

ËùÊôԺУ£ººÓ±±Ò½¿Æ´óѧ
ËùÊôԺϵ£º
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Àíѧ


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºsuswmk@163.com


¸öÈ˼òÊö :
ËÕËØÎÄ£¬²©Ê¿£¬½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦¡£1993Äê±ÏÒµÓÚºÓ±±Ò½¿Æ´óѧÁÙ´²Ò½Ñ§Ïµ£¬»ñѧʿѧλ£¬Í¬ÄêÁôУÈνÌ¡£2013Äê»ñµÃҽѧ²©Ê¿Ñ§Î»¡£2014Äê-2016ÄêÔÚÈÕ±¾´óÚæ´óѧ´Óʲ©Ê¿ºóÑо¿£¬Ö®ºóÒ»Ö±ÔÚºÓ±±Ò½¿Æ´óѧÈνÌÖÁ½ñ¡£×Ô¹¤×÷ÖÁ½ñ·¢±íÂÛÎÄ20¶àƪ£¬ÆäÖÐSCIÂÛÎÄ9ƪ£¬Ó°ÏìÒò×ӺϼÆÔ¼27£¬³ö°æÖø×÷1ƪ£¬»ñºÓ±±Ê¡¿Æ¼¼½ø²½½±3ÏÍê³É¹úÄÚÁìÏȵĿƼ¼³É¹û3ÏÒÑÍê³É¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðºÍºÓ±±Ê¡×ÔÈ»¿Æѧ»ù½ðµÈ¿ÎÌâ5ÏĿǰ³Ðµ£¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿ºÍºÓ±±Ê¡×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿¸÷1Ïî¡£

¿ÆÑй¤×÷ :
[1] Su S, Li Q, Liu Y, Xiong C, Li J, Zhang R, Niu Y, Zhao L, Wang Y, Guo H. Sesamin ameliorates doxorubicin-induced cardiotoxicity: Involvement of Sirt1 and Mn-SOD pathway. Toxicol Lett. 2014, 224(2):257¨C263. (IF:3.36)[2] Chen PP, Li CY, Han Y, Chen XY, Liu HL, Du YM, Su SW*, Zhang YJ*. N-[4-(4,6-Dimethyl-2-pyrimidinyloxy)-3-methylphenyl]-N'-[2-(dimethylamino)] benzoylurea induces cell-cycle arrest and apoptosis in human cancer cells. Anticancer Drugs. 2015 26(6):620-31. (IF:1.89)[3] Jiang YF, Chen XY, Ding T, Wang XF, Zhu ZN*, Su SW*. Comparative Efficacy and Safety of OADs in Management of GDM: Network Meta-analysis of Randomized Controlled Trials. J Clin Endocrinol Metab. 2015 100(5):2071-80. (IF:6.31)[4] Chen X, Zhang Y, Zhu Zh, Liu H, Guo H, Xiong Ch, Xie K, Zhang X, Su W*. The protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats. Molecular Medicine Reports. 201613(5):3953-60. (IF:1.554).[5] Wang LF, Su SW, Wang L, Zhang GQ, Zhang R, Niu YJ, Guo YS,Li CY(4), Jiang WB, Liu Y, Guo HC. Tert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genes. Am J Transl Res. 2015£»7(10):1724-35. (IF:3.4)[6] Liu H, Chen X, Han Y, Li C, Chen P, Su S, Zhang Y, Pan Z. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway. Biomed Pharmacother. 2014 68(3):267-75.£¨IF:2.068£©[7] Liu N, Li Y, Su S, Wang N, Wang H, Li J. Inhibition of cell migration by ouabain in the A549 human lung cancer cell line. Oncol Lett. 20136(2):475-479.(IF: 0.99)